We are delighted to see your interest in Freyr’s Webinar Series (FWS). The webinar on, “ASEAN Regulatory Strategy: Medical Devices”, was successfully concluded on March 10, 2021. Here is an archived version for your perusal.


What Was It All About?

In a nutshell, the session, presented by our in-house Regulatory experts – Zulkhurnain Utar, Associate Director, RA - Malaysia and Rahul Verma, Senior Manager, Regulatory Strategy, focused on:

  • Why Regulatory strategy must be part of corporate strategy?
  • ASEAN Medtech Market and Regulatory scenario
  • Factors influencing ASEAN Regulatory strategy
  • Importance of country-specific Regulatory connect
  • Freyr’s strategic framework
  • Merging compliance with cost-effective strategic approach (includes, clinical, testing and QMS components)
  • Key takeaways from the session

As a continuous practice, Freyr is destined to organize more webinar sessions related to Regulatory aspects of Life Sciences. We presume that you would like to be a part of all those sessions. If yes, let us have an opportunity to inform you about our next session.